摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(9ci)-7-甲基-1H-苯并咪唑-4-羧酸 | 745048-56-0

中文名称
(9ci)-7-甲基-1H-苯并咪唑-4-羧酸
中文别名
——
英文名称
7-Methyl-1H-benzimidazole-4-carboxylic acid
英文别名
4-Methyl-1H-benzimidazole-7-carboxylic acid;7-methyl-3H-benzimidazole-4-carboxylic acid
(9ci)-7-甲基-1H-苯并咪唑-4-羧酸化学式
CAS
745048-56-0
化学式
C9H8N2O2
mdl
MFCD21333191
分子量
176.175
InChiKey
ITRPGAZEZJLAIX-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    1.4
  • 重原子数:
    13
  • 可旋转键数:
    1
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.111
  • 拓扑面积:
    66
  • 氢给体数:
    2
  • 氢受体数:
    3

反应信息

  • 作为反应物:
    描述:
    (9ci)-7-甲基-1H-苯并咪唑-4-羧酸 以98的产率得到7-Methyl-6-nitro-1H-benzimidazole-4-carboxylic acid
    参考文献:
    名称:
    Methods of making 6-[(4,5-Dihydro-1H-imidazol-2-yl)amino-]-7-methyl-1H-benzimidazole-4-carbonitrile and its preferred salt form
    摘要:
    6-[(4,5-二氢-1H-咪唑-2-基)氨基]-7-甲基-1H-苯并咪唑-4-羧腈及其无水单乙酸盐,基本上不含2,3,7-三氨基-4,6-二甲基-1,9-苯并二氰基,可用于治疗α-2介导的疾病,如眼压增高。
    公开号:
    US20040167194A1
  • 作为产物:
    描述:
    6-Bromo-3-(formylamino)-4-methyl-2-nitro-benzoic acid 以81的产率得到(9ci)-7-甲基-1H-苯并咪唑-4-羧酸
    参考文献:
    名称:
    Methods of making 6-[(4,5-Dihydro-1H-imidazol-2-yl)amino-]-7-methyl-1H-benzimidazole-4-carbonitrile and its preferred salt form
    摘要:
    6-[(4,5-二氢-1H-咪唑-2-基)氨基]-7-甲基-1H-苯并咪唑-4-羧腈及其无水单乙酸盐,基本上不含2,3,7-三氨基-4,6-二甲基-1,9-苯并二氰基,可用于治疗α-2介导的疾病,如眼压增高。
    公开号:
    US20040167194A1
点击查看最新优质反应信息

文献信息

  • NOVEL INHIBITORS OF HEPATITIS C VIRUS REPLICATION
    申请人:Buckman Brad
    公开号:US20110152246A1
    公开(公告)日:2011-06-23
    The embodiments provide compounds of the general Formulae I, II, III, IV, or V as well as compositions, including pharmaceutical compositions, comprising a subject compound. The embodiments further provide treatment methods, including methods of treating a hepatitis C virus infection and methods of treating liver fibrosis, the methods generally involving administering to an individual in need thereof an effective amount of a subject compound or composition.
    实施例提供了一般式I、II、III、IV或V的化合物,以及包括药物组合物在内的组合物,其中包括一种主体化合物。实施例还提供了治疗方法,包括治疗丙型肝炎病毒感染的方法和治疗肝纤维化的方法,这些方法通常涉及向需要的个体施用一种主体化合物或组合物的有效量。
  • [EN] METHODS OF MAKING 6-[(4,5-DIHYDRO-1H-IMIDAZOL-2-YL)AMINO-]-7-METHYL-1H-BENZIMIDAZOLE-4-CARBONITRILE AND ITS PREFERRED SALT FORM<br/>[FR] PROCEDES DE FABRICATION DE 6-[(4,5-DIHYDRO-1H-IMIDAZOL-2-YL)AMINO-]-7-METHYL-1H-BENZIMIDAZOLE-4-CARBONITRILE ET FORME PREFEREE D'UN SEL DE CELUI-CI
    申请人:PROCTER & GAMBLE
    公开号:WO2004074279A1
    公开(公告)日:2004-09-02
    6-[(4,5-Dihydro-1H-imidazol-2-yl)amino-]-7-methyl-1H-benzimidazole-4-carbonitrile substantially free of 2,3,7-triamino-4,6-dimethyl-1,9-phenazinedicarbonitrile, and the anhydrous monoacetate salt thereof, are useful in the treatment of alpha-2 mediated disorders such as ocular hypertension.
    6-[(4,5-二氢-1H-咪唑-2-基)氨基]-7-甲基-1H-苯并咪唑-4-羧腈,基本上不含2,3,7-三氨基-4,6-二甲基-1,9-菲嗪二羧腈,以及其无水单乙酸盐,在治疗α-2介导的疾病,如眼压增高方面具有用处。
  • Methods of making 6-[(4,5-dihydro-1H-imidazol-2-yl)amino-]-7-methyl-1H-benzimidazole-4-carbonitrile and its preferred salt form
    申请人:Randall Lynn Jared
    公开号:US20060122248A1
    公开(公告)日:2006-06-08
    6-[(4,5-Dihydro-1H-imidazol-2-yl)amino-]-7-methyl-1H-benzimidazole-4-carbonitrile substantially free of 2,3,7-triamino-4,6-dimethyl-1,9-phenazinedicarbonitrile, and the anhydrous monoacetate salt thereof, are useful in the treatment of alpha-2 mediated disorders such as ocular hypertension.
    6-[(4,5-二氢-1H-咪唑-2-基)氨基]-7-甲基-1H-苯并咪唑-4-羧腈,基本上不含2,3,7-三氨基-4,6-二甲基-1,9-苯并二氰基的盐酸单乙酰化物,可用于治疗α-2介导的疾病,如眼压增高。
  • 6-[(4,5-Dihydro-1H-imidazol-2-yl)amino]-7-methyl-1H-benzimidazole-4-carbonitrile and its preferred salt
    申请人:The Board of Regents of the University of Nebraska
    公开号:US07304084B2
    公开(公告)日:2007-12-04
    6-[(4,5-Dihydro-1H-imidazol-2-yl)amino-]-7-methyl-1H-benzimidazole-4-carbonitrile substantially free of 2,3,7-triamino-4,6-dimethyl-1,9-phenazinedicarbonitrile, and the anhydrous monoacetate salt thereof, are useful in the treatment of alpha-2 mediated disorders such as ocular hypertension.
    6-[(4,5-二氢-1H-咪唑-2-基)氨基]-7-甲基-1H-苯并咪唑-4-碳腈及其无水单乙酸盐,在治疗α-2介导的疾病,如眼压增高方面有用,且基本不含2,3,7-三氨基-4,6-二甲基-1,9-苯并二氰基。
  • INSECTICIDAL COMPOUNDS
    申请人:Renold Peter
    公开号:US20110288089A1
    公开(公告)日:2011-11-24
    A compound of Formula (I): wherein A 1 , A 2 , A 3 , A 4 , A 5 , G 1 , R 1 , R 2 , R 3 and R 4 are as defined in claim 1 ; or a salt or N-oxide thereof. Furthermore, the present invention relates to processes and intermediates for preparing compounds of formula (I), to insecticidal, acaricidal, nematicidal and molluscicidal compositions comprising them and to methods of using them to combat and control insect, acarine, nematode and mollusc pests.
    公式(I)的化合物:其中A1、A2、A3、A4、A5、G1、R1、R2、R3和R4如权利要求1所定义;或其盐或N-氧化物。此外,本发明涉及制备公式(I)化合物的过程和中间体,涉及含有它们的杀虫剂、杀螨剂、杀线虫剂和杀软体动物剂的组合物,以及使用它们对抗和控制昆虫、螨虫、线虫和软体动物害虫的方法。
查看更多